Source: Eur Respir J 2009; 33: 1250-1253
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Lange C., Pai M., Drobniewski F., Migliori G. B.. Interferon-γ release assays for the diagnosis of active tuberculosis: sensible or silly?. Eur Respir J 2009; 33: 1250-1253

Member's Comments

No comment yet.

Related content which might interest you: Interferon-γ release assay tests to rule out active tuberculosis Source: Eur Respir J 2007; 30: 183-184 Year: 2007 T-cell interferon-γ release assays: can we do better? Source: Eur Respir J 2008; 32: 1428-1430 Year: 2008 Quantitative scoring of an interferon-γ assay for differentiating active from latent tuberculosis Source: Eur Respir J 2007; 30: 722-728 Year: 2007 Treatment for NTM: when, how... and what next? Source: ERS Course 2015 Year: 2015 Interferon-gamma release assays in tuberculosis contacts: is there a window period? Source: Eur Respir J 2011; 37: 215-217 Year: 2011 Time interval to conversion of interferon-? release assay after exposure to tuberculosis Source: Eur Respir J 2011; 37: 1447-1452 Year: 2011 TB or not TB... that is the question Source: International Congress 2019 – CCC Paediatric respiratory diseases Year: 2019 Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis Source: Eur Respir J 2007; 30: 321-332 Year: 2007 Moxifloxacin in multidrug-resistant tuberculosis: is there any indication for therapeutic drug monitoring?}, Source: Eur Respir J 2012; 40: 1051-1053 Year: 2012 Discordance between TSTs and IFN-γ release assays: the role of NTM and the relevance of mycobacterial sensitins Source: Eur Respir J 2010; 36: 215-216 Year: 2010 Discordance between TSTs and IFN-γ release assays: the role of NTM and the relevance of mycobacterial sensitins Source: Eur Respir J 2010; 36: 214-215 Year: 2010 The impact of corruption on multidrug-resistant tuberculosis: a quantitative assessment}, Source: Eur Respir J 2012; 40: 792-793 Year: 2012 Interferon gamma release assays in screening for tuberculosis – Can we use them in patients with sarcoidosis? Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011 Who is at risk for active tuberculosis? Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches Year: 2003 Indeterminate IFN-? release assay test results predict poor prognosis of active pulmonary tuberculosis Source: International Congress 2019 – Tuberculosis: diagnosis and scores Year: 2019 Indeterminate results of a tuberculosis-specific interferon-γ release assay in immunocompromised patients Source: Eur Respir J 2010; 35: 1179-1182 Year: 2010 Interferon-γ release assays do not identify more children with active tuberculosis than the tuberculin skin test Source: Eur Respir J 2009; 33: 1374-1382 Year: 2009 Can we predict tuberculosis cure? What tools are available? Source: Eur Respir J, 52 (5) 1801089; 10.1183/13993003.01089-2018 Year: 2018 Are interferon- gamma release assays useful for diagnosing active tuberculosis in a high-burden setting? Source: Eur Respir J 2011; 38: 649-656 Year: 2011